ViroVet NV
Budget
€10 — €0
EP Access
0
accredited persons
Staff
2
0.5 FTE
EU Grants
None
Mission & Goals
ViroVet is a pioneering company dedicated to the development of disruptive and innovative technologies for the control of viral diseases in livestock, with antiviral drugs for respiratory disease complexes and innovative vaccines for viral infections in swine leading the pipeline. The strategy of ViroVet is to provide novel solutions to be used alone or in combination with vaccines and biosecurity measures in order to provide livestock producers, national governments and international organizations with a multi-faceted arsenal of virus control weapons against endemic and epizootic viral diseases. It is clear that with the growing world population there is an increased demand for more protein-rich diets. With the increasing density of the livestock industry, the intensifying global trade and climate changes, there is an ever increased risk for the global spread of viral diseases, severely damaging livestock industry. ViroVet has already enlisted the support of a number of k (...)
EU Legislative Interests
ViroVet monitores everything linked to viral diseases in livestock and in particular epizootic and zoonotic outbreaks
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
FlandersBio (www.flanders.bio) and FlandersVaccines as part of FlandersBio Recently flanders.bio and mevia merged to BioVia, ViroVet is no longer presented at the board but is still member of the network organization
Organisation Members
none
Commissioner Meetings
No recorded meetings with EU commissioners.